Evidence map›Paper›PMID 35099644›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2022

Multifocal nivolumab immune-related adverse effects during asymptomatic SARS-CoV-2 infection: causality or casuality?

Alessandro Dinoto, Francesco Rossato, Tommaso Corradetti, Manuela Gioulis, Sandro Zambito Marsala, Franco Ferracci

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alessandro DinotoNeurology Unit, "San Martino" Hospital, AULSS 1 - Dolomiti, Viale Europa, 22, 32100, Belluno, Italy. alessandro.dinoto@hotmail.it.ORCID http://orcid.org/0000-0002-3249-4792
Francesco RossatoNeurology Clinic, Neuroscience Department, University of Padua, Padua, Italy.
Tommaso CorradettiNeurology Unit, "San Martino" Hospital, AULSS 1 - Dolomiti, Viale Europa, 22, 32100, Belluno, Italy.
Manuela GioulisNeurology Unit, "San Martino" Hospital, AULSS 1 - Dolomiti, Viale Europa, 22, 32100, Belluno, Italy.
Sandro Zambito MarsalaNeurology Unit, "San Martino" Hospital, AULSS 1 - Dolomiti, Viale Europa, 22, 32100, Belluno, Italy.
Franco FerracciNeurology Unit, "San Martino" Hospital, AULSS 1 - Dolomiti, Viale Europa, 22, 32100, Belluno, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19NivolumabCausalityHumansSARS-CoV-2Nivolumab

Identifiers

PMID35099644
PMCPMC8802258

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.